233 results
Page 4 of 12
6-K
EX-99
iankn0o tqf
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
96el3 vudtzkf15
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
eqw7g e8j
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
gz6ny7
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
EX-5.1
80yii3 v1m
31 Dec 20
Shelf registration (foreign)
4:37pm
F-3
EX-23.1
2mq62m10g qah
31 Dec 20
Shelf registration (foreign)
4:37pm
F-3
bfhwr60
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
33wc8kj9qhw7e82
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
wc3s6urq1
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
424B5
9oueou
13 Nov 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-1
u8px6ks1 ys9fh06evk
30 Oct 20
BioLineRx Announces Positive Results from Interim Analysis of
7:09am
6-K
EX-10.1
kec92xr
25 Sep 20
Current report (foreign)
4:33pm
424B5
3r4 1zj543lnpnc
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
scyjjhx0cks1g 9652
24 Sep 20
Current report (foreign)
4:30pm
6-K
EX-99
o67v184l
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-99
vhkva06dotvd
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-99
4s2gi04d7fm0g1i2u
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
POS AM
EX-23.1
w0ris5fv
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
POS AM
o58y21d
10 Aug 20
Prospectus update (post-effective amendment)
12:00am